By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


Company News
CytRx Corporation (CYTR) Unveils Novel LADR (Linker Activated Drug Release) Technology Platform 6/30/2015 7:20:27 AM
CytRx Corporation (CYTR) Announces Presentation Of Interim Phase 2 Data For Aldoxorubicin For HIV-Related Kaposi's Sarcoma 6/29/2015 9:45:53 AM
Cheryl Cohen, Former Medivation, Inc. (MDVN) Chief Commercial Officer, Joins CytRx Corporation (CYTR) Board Of Directors 6/24/2015 7:58:12 AM
CytRx Corporation (CYTR) Announces Settlement Of Stockholder Derivative Lawsuit In Delaware 6/2/2015 11:31:48 AM
CytRx Corporation (CYTR) To Present Aldoxorubicin Clinical Data At The 2015 ASCO Annual Meeting 5/27/2015 10:23:35 AM
CytRx Corporation (CYTR) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/26/2015 10:11:46 AM
CytRx Corporation (CYTR) Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results In Glioblastoma Multiforme (Brain Cancer) 5/21/2015 8:35:36 AM
CytRx Corporation (CYTR) Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage And Improved Quality Of Life In Chemotherapy Resistant Cancers 5/4/2015 7:45:08 AM
CytRx Corporation (CYTR) Reports First Quarter 2015 Financial Results 5/1/2015 8:38:38 AM
CytRx Corporation (CYTR) Announces Publication Of Glioblastoma Clinical Case Study In Journal Of Nuclear Medicine & Radiation Therapy 4/29/2015 7:33:59 AM